Market Overview

63 Biggest Movers From Yesterday



  • Audentes Therapeutics Inc (NASDAQ: BOLD) shares climbed 106% to close at $58.93 on Tuesday after the company agreed to be acquired by Astellas Pharma for $60 per share in cash.
  • DarioHealth Corp. (NASDAQ: DRIO) rose 49.1% to close at $7.47 after the company reported the launch of Dario-powered digital diabetes program on
  • Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) climbed 41% to close at $4.47.
  • Akerna Corp. (NASDAQ: KERN) gained 38% to close at $12.50.
  • Atreca, Inc. (NASDAQ: BCEL) gained 32.3% to close at $13.34 after the company reported the FDA clearance of investigational new drug application for ATRC-101.
  • ViewRay, Inc. (NASDAQ: VRAY) shares rose 30.6% to close at $4.44 after the company announced it has signed a memorandum of understanding for collaboration with Elekta AB and Medtronic. The company also announced a $75 million common stock offering.
  • Calyxt, Inc. (NASDAQ: CLXT) shares rose 28.8% to close at $4.70.
  • Lands' End, Inc. (NASDAQ: LE) shares gained 21% to close at $14.24 after reporting upbeat Q3 earnings.
  • Equillium, Inc. (NASDAQ: EQ) gained 20.5% to close at $3.99.
  • Iterum Therapeutics plc (NASDAQ: ITRM) rose 20.2% to close at $3.15.
  • Wrap Technologies, Inc. (NASDAQ: WRTC) shares surged 17.2% to close at $5.05.
  • uniQure N.V. (NASDAQ: QURE) rose 16.7% to close at $63.92 after analysts from Goldman Sachs and Cowen & Co initiated coverage on the company's stock with bullish ratings.
  • Super League Gaming, Inc. (NASDAQ: SLGG) gained 15.8% to close at $2.71.
  • Mesa Air Group, Inc. (NASDAQ: MESA) climbed 15.6% to close at $8.09.
  • Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares rose 15.1% to close at $45.61 after the company disclosed that AXS-12 achieved primary endpoint in concert Phase 2 trial in narcolepsy.
  • Rubius Therapeutics, Inc. (NASDAQ: RUBY) gained 14.4% to close at $8.27.
  • Akebia Therapeutics, Inc. (NASDAQ: AKBA) surged 14.1% to close at $6.07.
  • Chimerix, Inc. (NASDAQ: CMRX) gained 13.8% to close at $2.72.
  • Stage Stores, Inc. (NYSE: SSI) shares climbed 13.8% to close at $5.45.
  • Synlogic, Inc. (NASDAQ: SYBX) rose 13.5% to close at $2.35.
  • Yunji Inc. (NASDAQ: YJ) climbed 13% to close at $4.70.
  • Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) gained 11.4% to close at $29.93.
  • Ardelyx, Inc. (NASDAQ: ARDX) jumped 11.2% to close at $8.05 after the company announced positive topline results from its Phase 3 of PHREEDOM. Jefferies also maintained its Buy rating and raised its price target from $6 to $11 per share.
  • Zovio Inc (NASDAQ: ZVO) gained 11% to close at $2.23.
  • Harmony Gold Mining Company Limited (NYSE: HMY) rose 10.8% to close at $3.28 amid US-China trade uncertainty after Trump implied a deal many not be reached until 2020. Continuing trade war concerns have led investors into 'safe-haven' assets such as gold and silver.
  • Xenon Pharmaceuticals Inc. (NASDAQ: XENE) gained 10.3% to close at $13.58.
  • Proteostasis Therapeutics, Inc. (NASDAQ: PTI) rose 10% to close at $2.64.
  • REGENXBIO Inc. (NASDAQ: RGNX) jumped 9.4% to close at $44.50.
  • Sibanye Gold Limited (NYSE: SBGL) rose 9.3% to close at $8.83.
  • Sorrento Therapeutics, Inc. (NASDAQ: SRNE) shares rose 9.1% to close at $3.73.
  • Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) gained 9% to close at $4.12. Merrimack received $5 million milestone payment from Ipsen, triggered by Ipsen's decision to progress trial evaluating ONIVYDE.
  • Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) gained 8.4% to close at $68.66. Arrowhead Pharmaceuticals said it intends to offer 4 million shares of its common stock in an underwritten public offering.
  • Sangamo Therapeutics, Inc. (NASDAQ: SGMO) climbed 6.4% to close at $11.37 in sympathy with Audentes Therapeutics after the company announced it will be acquired by Astellas Pharma for $60 per share in cash.
  • Amneal Pharmaceuticals Inc (NYSE: AMRX) rose 5.2% to close at $4.04 after the company reported the FDA approval and launch of generic carafate.
  • AK Steel Holding Corporation (NYSE: AKS) rose 4.2% to close at $3.01 after Cleveland-Cliffs announced plans to acquire the company for $3.36 per share.

Check out these big penny stock gainers and losers


  • ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) shares tumbled 49.6% to close at $2.62 on Tuesday after the company priced a 5.2 million ADS offering at $2.50 per ADS.
  • Protagonist Therapeutics, Inc. (NASDAQ: PTGX) dropped 47% to close at $4.69 after the company reported preliminary Phase 2 results with hepcidin mimetic PTG-300 in the treatment of transfusion dependent beta-thalassemia.
  • Cara Therapeutics, Inc. (NASDAQ: CARA) dropped 34.6% to close at $16.93 after the company reported mixed results from its Phase 2 trial of Oral Korsuva in chronic kidney disease patients with moderate-to-severe pruritus.
  • Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) dipped 32.4% to close at $5.06 after the company announced positive top-line results from Part 1 of the adaptive Phase 3 study dubbed RENEW, which evaluated ADX-102 (topical ocular reproxalap) for dry eye syndrome. ADX-102 was found statistically superior to vehicle in Ocular Discomfort &4-Symptom Questionnaire ocular endpoints for dryness, discomfort, burning, grittiness and stinging. For the co-primary endpoint of fluorescein nasal region ocular staining, it did not reach statistical significance.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) shares fell 29% to close at $11.67.
  • CBL & Associates Properties, Inc. (NYSE: CBL) dropped 24.4% to close at $1.02 after announcing the suspension of common and preferred stock dividends. The company says it sees a decline in net operating income as a result of ‘heightened retailer bankruptcies, restructurings and store closings in 2019.’
  • CooTek (Cayman) Inc. (NYSE: CTK) fell 22.6% to close at $4.55.
  • Resonant Inc. (NASDAQ: RESN) dropped 18.1% to close at $1.76.
  • Nine Energy Service, Inc. (NYSE: NINE) fell 16.2% to close at $4.61.
  • Liquid Media Group Ltd. (NASDAQ: YVR) dipped 16% to close at $2.89.
  • Duluth Holdings Inc. (NASDAQ: DLTH) dropped 14.8% to close at $7.71. Stifel Nicolaus maintained Duluth Holdings with a Hold and lowered the price target from $11 to $9.
  • Just Energy Group Inc. (NYSE: JE) fell 14.1% to close at $1.95 on continued momentum after the company announced it would suspend the dividend on its Series A preferred stock.
  • Puma Biotechnology, Inc. (NASDAQ: PBYI) fell 12.9% to close at $9.35
  • Safe-T Group Ltd (NASDAQ: SFET) dipped 11.9% to close at $5.40.
  • Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) dropped 11.7% to close at $5.05.
  • Ruhnn Holding Limited (NASDAQ: RUHN) dipped 11.4% to close at $6.29.
  • Plug Power Inc. (NASDAQ: PLUG) fell 11.1% to close at $3.38 after the company announced a 40 million share common stock offering.
  • Eyenovia, Inc. (NASDAQ: EYEN) fell 10.7% to close at $3.59.
  • Cleveland-Cliffs Inc. (NYSE: CLF) fell 10.7% to close at $7.51 after the company announced it will acquire AK Steel for approximately $3 billion.
  • InMode Ltd. (NASDAQ: INMD) dropped 10.2% to close at $43.99.
  • Tufin Software Technologies Ltd. (NYSE: TUFN) dropped 9.7% to close at $17.23 after the company announced the launch of secondary public offering of ordinary shares.
  • Akari Therapeutics, Plc (NASDAQ: AKTX) shares declined 9.3% to close at $1.96.
  • TTEC Holdings Inc (NASDAQ: TTEC) fell 9.3% to close at $40.57 after the company reported a 3 million share offering by selling shareholders.
  • Adient plc (NYSE: ADNT) fell 8.5% to close at $20.58.
  • Avita Medical Limited (NASDAQ: RCEL) shares dropped 7.2% to close at $7.84.
  • Venator Materials PLC (NYSE: VNTR) dropped 6.7% to close at $3.61.
  • RPC, Inc. (NYSE: RES) fell 5.9% to close at $3.66.
  • DouYu International Holdings Ltd (NASDAQ: DOYU) dropped 4.1% to close at $7.20 after JP Morgan downgraded the company's stock from Overweight to Neutral and lowered the price target from $10 to $8.

Related Articles (ADNT + AKBA)

View Comments and Join the Discussion!

Posted-In: Movers From YesterdayNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at